Canada fines Cryptomus a record $126 million for severe anti-money laundering (AML) violations, setting a firm regulatory ...
Canada’s FINTRAC fined Cryptomus $126M for failing to report over 2,500 suspicious cryptocurrency transactions.
Acute myeloid leukemia (AML), an aggressive and often fatal blood cancer, has long resisted a class of drugs called ...
Retail Banker International on MSN
Money laundering costs $5.5tn across the globe: Napier AI
Napier AI’s 2025/26 global AML Index, researched by Napier AI in partnership with Global Data, ranks 40 global markets based ...
– 100% CR rate with 7+3 in newly diagnosed NPM1-m and KMT2A-r AML – – 56% CR/CRh with ven/aza in menin inhibitor naïve patients with R/R AML – – 80% of patients remain on trial as of data cutoff, ...
Cryptopolitan on MSN
Canada slaps record‑breaking C$176.9 m fine on Xeltox for crypto AML failures
Canada’s financial watchdog has issued a record fine of C$176.9 million ($126 million) against Xeltox, the company known ...
Time and again, seemingly successful bank mergers have been rocked by revelations of poor anti-money-laundering compliance. Assessing the AML risk of a potential merger partner is extremely tricky, ...
– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – ...
– Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML – – FLT3 mutations occur in approximately 30% of ...
Kura Oncology and Kyowa Kirin announced that clinical data from the KOMET-007 trial, evaluating ziftomenib in combination with the standard chemotherapy regimen of cytarabine and daunorubicin (7+3) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results